MVM
Medicxi Ventures Management Portfolio holdings
AUM
$427M
This Quarter Return
+5.91%
1 Year Return
+42.94%
3 Year Return
+262.94%
5 Year Return
+109.92%
10 Year Return
–
AUM
$558M
AUM Growth
+$558M
(+225%)
Cap. Flow
+$398M
Cap. Flow
% of AUM
71.34%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
CNTA
Centessa Pharmaceuticals
CNTA
|
$398M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTA
1
Centessa Pharmaceuticals
CNTA
$2.25B
| $398M | 71.34% | +17,923,892 | New | +$398M |
|
2
Phathom Pharmaceuticals
PHAT
$864M
| $70M | 12.54% | 2,067,861 | – | – |
|
3
Vaxcyte
PCVX
$4B
| $42.5M | 7.61% | 1,887,478 | – | – |
|
4
Merus
MRUS
$4.98B
| $33.7M | 6.04% | 1,600,000 | – | – |
|
|
CMPI
5
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
| $8.95M | 1.6% | 1,501,716 | – | – |
|
|
OBSV
6
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $4.76M | 0.85% | 1,570,000 | – | – |
|